SOLUTION NMR

NMR Experiment
Experiment Type Sample Contents Ionic Strength Solvent pH Pressure Temprature (K)
1 1D 1H 6 mg/mL peptide, 0.03 % TMS, DMSO NA DMSO 0.0 1 293
2 2D NOESY 6 mg/mL peptide, 0.03 % TMS, DMSO NA DMSO 0.0 1 293
3 2D ROESY 6 mg/mL peptide, 0.03 % TMS, DMSO NA DMSO 0.0 1 293
4 2D TOCSY 6 mg/mL peptide, 0.03 % TMS, DMSO NA DMSO 0.0 1 293
5 2D DQF-COSY 6 mg/mL peptide, 0.03 % TMS, DMSO NA DMSO 0.0 1 293
6 2D 1H-13C HSQC-ed 6 mg/mL peptide, 0.03 % TMS, DMSO NA DMSO 0.0 1 293
7 2D 1H-15N HSQC 6 mg/mL peptide, 0.03 % TMS, DMSO NA DMSO 0.0 1 293
8 2D 1H-13C HMBC 6 mg/mL peptide, 0.03 % TMS, DMSO NA DMSO 0.0 1 293
9 2D 1H-13C HSQC-TOCSY 6 mg/mL peptide, 0.03 % TMS, DMSO NA DMSO 0.0 1 293
NMR Spectrometer Information
Spectrometer Manufacturer Model Field Strength
1 Bruker AVANCE III 600
NMR Refinement
Method Details Software
na This is conformation B (CT) of the 8-residue cyclic peptide present in the same NMR sample in d6-DMSO. A-CC conformation (50%) has cis MLU-3 and cis MLU-7 (pdb 7UBD) and B-CT (50%) conformation has cis MLU-3 and trans MLU-7 1
NMR Ensemble Information
Conformer Selection Criteria target function
Conformers Calculated Total Number 100
Conformers Submitted Total Number 20
Representative Model 1 (medoid)
Computation: NMR Software
# Classification Version Software Name Author
1 refinement 3.98.13 CYANA Guntert , Mumenthaler, and Wuthrich
2 peak picking 1.370 NMRFAM-SPARKY Lee, Tonelli, Markley
3 processing 10.9 NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4 data analysis 4.0.9 TopSpin Bruker Biospin
5 data analysis 5.21.6 PdbStat Tejero, Snyder, Mao, Aramini, Montelione
6 structure calculation 3.98.13 CYANA Guntert , Mumenthaler, and Wuthrich
Feedback Form
Name
Email
Institute
Feedback